TY - JOUR AU - Henske, E. P. AU - Jóźwiak, S. AU - Kingswood, J. C. AU - Sampson, J. R. AU - Thiele, E. A. PY - 2016 DA - 2016// TI - Tuberous sclerosis complex JO - Nat Rev Dis Primer VL - 2 UR - https://doi.org/10.1038/nrdp.2016.35 DO - 10.1038/nrdp.2016.35 ID - Henske2016 ER - TY - JOUR AU - Curatolo, P. AU - Moavero, R. AU - Vries, P. J. PY - 2015 DA - 2015// TI - Neurological and neuropsychiatric aspects of tuberous sclerosis complex JO - Lancet Neurol VL - 14 UR - https://doi.org/10.1016/S1474-4422(15)00069-1 DO - 10.1016/S1474-4422(15)00069-1 ID - Curatolo2015 ER - TY - JOUR AU - Schwartz, R. A. AU - Fernández, G. AU - Kotulska, K. AU - Jóźwiak, S. PY - 2007 DA - 2007// TI - Tuberous sclerosis complex: advances in diagnosis, genetics, and management JO - J Am Acad Dermatol VL - 57 UR - https://doi.org/10.1016/j.jaad.2007.05.004 DO - 10.1016/j.jaad.2007.05.004 ID - Schwartz2007 ER - TY - JOUR AU - Sampson, J. R. PY - 2009 DA - 2009// TI - Therapeutic targeting of mTOR in tuberous sclerosis JO - Biochem Soc Trans VL - 37 UR - https://doi.org/10.1042/BST0370259 DO - 10.1042/BST0370259 ID - Sampson2009 ER - TY - JOUR AU - Chu-Shore, C. J. AU - Major, P. AU - Camposano, S. AU - Muzykewicz, D. AU - Thiele, E. A. PY - 2010 DA - 2010// TI - The natural history of epilepsy in tuberous sclerosis complex JO - Epilepsia VL - 51 UR - https://doi.org/10.1111/j.1528-1167.2009.02474.x DO - 10.1111/j.1528-1167.2009.02474.x ID - Chu-Shore2010 ER - TY - JOUR AU - Vignoli, A. AU - Briola, F. AU - Turner, K. AU - Scornavacca, G. AU - Chiesa, V. AU - Zambrelli, E. PY - 2013 DA - 2013// TI - Epilepsy in TSC: certain etiology does not mean certain prognosis JO - Epilepsia VL - 54 UR - https://doi.org/10.1111/epi.12430 DO - 10.1111/epi.12430 ID - Vignoli2013 ER - TY - JOUR AU - Saxena, A. AU - Sampson, J. R. PY - 2015 DA - 2015// TI - Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments JO - Semin Neurol VL - 35 UR - https://doi.org/10.1055/s-0035-1552616 DO - 10.1055/s-0035-1552616 ID - Saxena2015 ER - TY - JOUR AU - Joinson, C. AU - O’Callaghan, F. J. AU - Osborne, J. P. AU - Martyn, C. AU - Harris, T. AU - Bolton, P. F. PY - 2003 DA - 2003// TI - Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex JO - Psychol Med VL - 33 UR - https://doi.org/10.1017/S0033291702007092 DO - 10.1017/S0033291702007092 ID - Joinson2003 ER - TY - JOUR AU - Crino, P. B. AU - Nathanson, K. L. AU - Henske, E. P. PY - 2006 DA - 2006// TI - The tuberous sclerosis complex JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMra055323 DO - 10.1056/NEJMra055323 ID - Crino2006 ER - TY - JOUR AU - Curatolo, P. AU - Bombardieri, R. AU - Jozwiak, S. PY - 2008 DA - 2008// TI - Tuberous sclerosis JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61279-9 DO - 10.1016/S0140-6736(08)61279-9 ID - Curatolo2008 ER - TY - JOUR AU - Eijkemans, M. J. C. AU - Wal, W. AU - Reijnders, L. J. AU - Roes, K. C. B. AU - Doorn-Khosrovani, S. B. AU - Pelletier, C. PY - 2015 DA - 2015// TI - Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands JO - Am J Kidney Dis VL - 66 UR - https://doi.org/10.1053/j.ajkd.2015.05.016 DO - 10.1053/j.ajkd.2015.05.016 ID - Eijkemans2015 ER - TY - JOUR AU - O’Callaghan, F. J. AU - Noakes, M. J. AU - Martyn, C. N. AU - Osborne, J. P. PY - 2004 DA - 2004// TI - An epidemiological study of renal pathology in tuberous sclerosis complex JO - BJU Int VL - 94 UR - https://doi.org/10.1111/j.1464-410X.2004.05046.x DO - 10.1111/j.1464-410X.2004.05046.x ID - O’Callaghan2004 ER - TY - JOUR AU - Adriaensen, M. E. AU - Schaefer-Prokop, C. M. AU - Stijnen, T. AU - Duyndam, D. A. AU - Zonnenberg, B. A. AU - Prokop, M. PY - 2009 DA - 2009// TI - Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature JO - Eur J Neurol VL - 16 UR - https://doi.org/10.1111/j.1468-1331.2009.02567.x DO - 10.1111/j.1468-1331.2009.02567.x ID - Adriaensen2009 ER - TY - JOUR AU - Krueger, D. A. AU - Northrup, H. AU - Northrup, H. AU - Krueger, D. A. AU - Roberds, S. AU - Smith, K. PY - 2013 DA - 2013// TI - Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference JO - Pediatr Neurol VL - 49 UR - https://doi.org/10.1016/j.pediatrneurol.2013.08.002 DO - 10.1016/j.pediatrneurol.2013.08.002 ID - Krueger2013 ER - TY - JOUR AU - Bissler, J. J. AU - McCormack, F. X. AU - Young, L. R. AU - Elwing, J. M. AU - Chuck, G. AU - Leonard, J. M. PY - 2008 DA - 2008// TI - Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa063564 DO - 10.1056/NEJMoa063564 ID - Bissler2008 ER - TY - JOUR AU - Davies, D. M. AU - Vries, P. J. AU - Johnson, S. R. AU - McCartney, D. L. AU - Cox, J. A. AU - Serra, A. L. PY - 2011 DA - 2011// TI - Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0445 DO - 10.1158/1078-0432.CCR-11-0445 ID - Davies2011 ER - TY - JOUR AU - McCormack, F. X. AU - Inoue, Y. AU - Moss, J. AU - Singer, L. G. AU - Strange, C. AU - Nakata, K. PY - 2011 DA - 2011// TI - Efficacy and safety of sirolimus in lymphangioleiomyomatosis JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1100391 DO - 10.1056/NEJMoa1100391 ID - McCormack2011 ER - TY - JOUR AU - Cabrera-López, C. AU - Martí, T. AU - Catalá, V. AU - Torres, F. AU - Mateu, S. AU - Ballarín, J. AU - Torra, R. PY - 2012 DA - 2012// TI - Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial JO - Orphanet J Rare Dis VL - 7 UR - https://doi.org/10.1186/1750-1172-7-87 DO - 10.1186/1750-1172-7-87 ID - Cabrera-López2012 ER - TY - STD TI - Novartis. Votubia (everolimus). Summary of Product Characteristics. 2016. https://www.medicines.org.uk/emc/medicine/25054. Accessed 9 Nov 2016. UR - https://www.medicines.org.uk/emc/medicine/25054 ID - ref19 ER - TY - JOUR AU - Bissler, J. J. AU - Kingswood, J. C. AU - Radzikowska, E. AU - Zonnenberg, B. A. AU - Frost, M. AU - Belousova, E. PY - 2013 DA - 2013// TI - Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61767-X DO - 10.1016/S0140-6736(12)61767-X ID - Bissler2013 ER - TY - JOUR AU - Franz, D. N. AU - Belousova, E. AU - Sparagana, S. AU - Bebin, E. M. AU - Frost, M. AU - Kuperman, R. PY - 2013 DA - 2013// TI - Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61134-9 DO - 10.1016/S0140-6736(12)61134-9 ID - Franz2013 ER - TY - JOUR AU - French, J. A. AU - Lawson, J. A. AU - Yapici, Z. AU - Ikeda, H. AU - Polster, T. AU - Nabbout, R. PY - 2016 DA - 2016// TI - Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31419-2 DO - 10.1016/S0140-6736(16)31419-2 ID - French2016 ER - TY - JOUR AU - Franz, D. N. AU - Belousova, E. AU - Sparagana, S. AU - Bebin, E. M. AU - Frost, M. AU - Kuperman, R. PY - 2014 DA - 2014// TI - Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70489-9 DO - 10.1016/S1470-2045(14)70489-9 ID - Franz2014 ER - TY - JOUR AU - Bissler, J. J. AU - Kingswood, J. C. AU - Radzikowska, E. AU - Zonnenberg, B. A. AU - Frost, M. AU - Belousova, E. PY - 2016 DA - 2016// TI - Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial JO - Nephrol Dial Transplant VL - 31 UR - https://doi.org/10.1093/ndt/gfv249 DO - 10.1093/ndt/gfv249 ID - Bissler2016 ER - TY - JOUR AU - Porta, C. AU - Osanto, S. AU - Ravaud, A. AU - Climent, M. -. A. AU - Vaishampayan, U. AU - White, D. A. PY - 2011 DA - 2011// TI - Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma JO - Eur J Cancer VL - 47 UR - https://doi.org/10.1016/j.ejca.2011.02.014 DO - 10.1016/j.ejca.2011.02.014 ID - Porta2011 ER - TY - JOUR AU - Peterson, M. E. PY - 2013 DA - 2013// TI - Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial JO - Support Care Cancer VL - 21 UR - https://doi.org/10.1007/s00520-013-1826-3 DO - 10.1007/s00520-013-1826-3 ID - Peterson2013 ER - TY - JOUR AU - Yardley, D. A. PY - 2014 DA - 2014// TI - Adverse event management of mTOR inhibitors during treatment of hormone receptor-positive advanced breast cancer: considerations for oncologists JO - Clin Breast Cancer VL - 14 UR - https://doi.org/10.1016/j.clbc.2014.03.002 DO - 10.1016/j.clbc.2014.03.002 ID - Yardley2014 ER - TY - JOUR AU - Zaza, G. AU - Tomei, P. AU - Ria, P. AU - Granata, S. AU - Boschiero, L. AU - Lupo, A. PY - 2013 DA - 2013// TI - Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors JO - Clin Dev Immunol VL - 2013 UR - https://doi.org/10.1155/2013/403280 DO - 10.1155/2013/403280 ID - Zaza2013 ER - TY - JOUR AU - Sparagana, S. AU - Franz, D. AU - Krueger, D. AU - Bissler, J. AU - Berkowitz, N. AU - Burock, K. PY - 2016 DA - 2016// TI - Pooled analysis of menstrual irregularities from 3 major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex (P4.250) JO - Neurology VL - 86 ID - Sparagana2016 ER - TY - JOUR AU - Bissler, J. J. AU - Radzikowska, E. AU - Zonnenberg, B. AU - Belousova, E. AU - Frost, M. D. AU - Sauter, M. PY - 2016 DA - 2016// TI - Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: final long-term results from EXIST-2 JO - J Urol VL - 195 UR - https://doi.org/10.1016/j.juro.2016.02.2408 DO - 10.1016/j.juro.2016.02.2408 ID - Bissler2016 ER - TY - JOUR AU - Budde, K. AU - Zonnenberg, B. A. AU - Frost, M. AU - Cheung, W. AU - Urva, S. AU - Brechenmacher, T. PY - 2016 DA - 2016// TI - Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis JO - Br J Clin Pharmacol VL - 81 UR - https://doi.org/10.1111/bcp.12834 DO - 10.1111/bcp.12834 ID - Budde2016 ER - TY - JOUR AU - Kingswood, J. C. AU - Jozwiak, S. AU - Belousova, E. D. AU - Frost, M. D. AU - Kuperman, R. A. AU - Bebin, E. M. PY - 2014 DA - 2014// TI - The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, phase 3 trial EXIST-1 JO - Nephrol Dial Transplant VL - 29 UR - https://doi.org/10.1093/ndt/gfu013 DO - 10.1093/ndt/gfu013 ID - Kingswood2014 ER - TY - STD TI - NHS England. Clinical Commissioning Policy Statement: Everolimus (Votubia®) for treatment of angiomyolipomas associated with tuberous sclerosis. 2016. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2016/06/b14x09-ps-everolimus-aml.pdf. Accessed 9 Nov 2016. UR - https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2016/06/b14x09-ps-everolimus-aml.pdf ID - ref33 ER - TY - JOUR AU - Agricola, K. AU - Tudor, C. AU - Krueger, D. AU - Franz, D. N. PY - 2013 DA - 2013// TI - Nursing implications for the lifelong management of tuberous sclerosis complex JO - J Neurosci Nurs VL - 45 UR - https://doi.org/10.1097/JNN.0b013e3182986146 DO - 10.1097/JNN.0b013e3182986146 ID - Agricola2013 ER - TY - JOUR AU - Franz, D. N. AU - Belousova, E. AU - Sparagana, S. AU - Bebin, E. M. AU - Frost, M. D. AU - Kuperman, R. PY - 2016 DA - 2016// TI - Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158476 DO - 10.1371/journal.pone.0158476 ID - Franz2016 ER - TY - JOUR AU - Franz, D. N. AU - Agricola, K. AU - Mays, M. AU - Tudor, C. AU - Care, M. M. AU - Holland-Bouley, K. PY - 2015 DA - 2015// TI - Everolimus for subependymal giant cell astrocytoma: 5-year final analysis JO - Ann Neurol VL - 78 UR - https://doi.org/10.1002/ana.24523 DO - 10.1002/ana.24523 ID - Franz2015 ER - TY - JOUR AU - Billing, H. AU - Burmeister, G. AU - Plotnicki, L. AU - Ahlenstiel, T. AU - Fichtner, A. AU - Sander, A. PY - 2013 DA - 2013// TI - Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients JO - Transpl Int VL - 26 UR - https://doi.org/10.1111/tri.12148 DO - 10.1111/tri.12148 ID - Billing2013 ER - TY - JOUR AU - Pape, L. AU - Offner, G. AU - Kreuzer, M. AU - Froede, K. AU - Drube, J. AU - Kanzelmeyer, N. PY - 2010 DA - 2010// TI - De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation JO - Am J Transplant VL - 10 UR - https://doi.org/10.1111/j.1600-6143.2010.03266.x DO - 10.1111/j.1600-6143.2010.03266.x ID - Pape2010 ER - TY - JOUR AU - Hymes, L. C. AU - Warshaw, B. L. PY - 2011 DA - 2011// TI - Linear growth in pediatric renal transplant recipients receiving sirolimus JO - Pediatr Transplant VL - 15 UR - https://doi.org/10.1111/j.1399-3046.2011.01574.x DO - 10.1111/j.1399-3046.2011.01574.x ID - Hymes2011 ER - TY - JOUR AU - Förster, J. AU - Ahlenstiel-Grunow, T. AU - Zapf, A. AU - Mynarek, M. AU - Pape, L. PY - 2016 DA - 2016// TI - Pubertal development in pediatric kidney transplant patients receiving mammalian target of rapamycin inhibitors or conventional immunosuppression JO - Transplantation VL - 100 UR - https://doi.org/10.1097/TP.0000000000001037 DO - 10.1097/TP.0000000000001037 ID - Förster2016 ER - TY - JOUR AU - Cavanaugh, T. M. AU - Schoenemen, H. AU - Goebel, J. PY - 2012 DA - 2012// TI - The impact of sirolimus on sex hormones in male adolescent kidney recipients JO - Pediatr Transplant VL - 16 UR - https://doi.org/10.1111/j.1399-3046.2012.01647.x DO - 10.1111/j.1399-3046.2012.01647.x ID - Cavanaugh2012 ER - TY - JOUR AU - Fritsche, L. AU - Budde, K. AU - Dragun, D. AU - Einecke, G. AU - Diekmann, F. AU - Neumayer, H. -. H. PY - 2004 DA - 2004// TI - Testosterone concentrations and sirolimus in male renal transplant patients JO - Am J Transplant VL - 4 UR - https://doi.org/10.1046/j.1600-6135.2003.00279.x DO - 10.1046/j.1600-6135.2003.00279.x ID - Fritsche2004 ER - TY - JOUR AU - Lee, S. AU - Coco, M. AU - Greenstein, S. M. AU - Schechner, R. S. AU - Tellis, V. A. AU - Glicklich, D. G. PY - 2005 DA - 2005// TI - The effect of sirolimus on sex hormone levels of male renal transplant recipients JO - Clin Transplant VL - 19 UR - https://doi.org/10.1111/j.1399-0012.2005.00257.x DO - 10.1111/j.1399-0012.2005.00257.x ID - Lee2005 ER - TY - JOUR AU - Tondolo, V. AU - Citterio, F. AU - Panocchia, N. AU - Nanni, G. AU - Castagneto, M. PY - 2005 DA - 2005// TI - Sirolimus impairs improvement of the gonadal function after renal transplantation JO - Am J Transplant VL - 5 UR - https://doi.org/10.1111/j.1600-6143.2005.00604.x DO - 10.1111/j.1600-6143.2005.00604.x ID - Tondolo2005 ER - TY - STD TI - CTEP. CTCAE v3. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed 9 Nov 2016. UR - https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm ID - ref45 ER - TY - STD TI - Chemocare. Pneumonia - Chemotherapy side effects. http://chemocare.com/chemotherapy/side-effects/pneumonia.aspx. Accessed 9 Nov 2016. UR - http://chemocare.com/chemotherapy/side-effects/pneumonia.aspx ID - ref46 ER - TY - JOUR AU - Chuang, P. AU - Langone, A. J. PY - 2007 DA - 2007// TI - Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus JO - Am J Transplant VL - 7 UR - https://doi.org/10.1111/j.1600-6143.2006.01678.x DO - 10.1111/j.1600-6143.2006.01678.x ID - Chuang2007 ER - TY - JOUR AU - Nolan, A. AU - McIntosh, W. B. AU - Allam, B. F. AU - Lamey, P. J. PY - 1991 DA - 1991// TI - Recurrent aphthous ulceration: vitamin B1, B2 and B6 status and response to replacement therapy JO - J Oral Pathol Med VL - 20 UR - https://doi.org/10.1111/j.1600-0714.1991.tb00950.x DO - 10.1111/j.1600-0714.1991.tb00950.x ID - Nolan1991 ER - TY - JOUR AU - Wray, D. PY - 1982 DA - 1982// TI - A double-blind trial of systemic zinc sulfate in recurrent aphthous stomatitis JO - Oral Surg Oral Med Oral Pathol VL - 53 UR - https://doi.org/10.1016/0030-4220(82)90459-5 DO - 10.1016/0030-4220(82)90459-5 ID - Wray1982 ER - TY - STD TI - Brocklehurst P, Tickle M, Glenny A-M, Lewis MA, Pemberton MN, Taylor J, et al. Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005411.pub2/abstract. Accessed 9 Nov 2016. UR - http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005411.pub2/abstract ID - ref50 ER - TY - JOUR AU - Natah, S. S. AU - Konttinen, Y. T. AU - Enattah, N. S. AU - Ashammakhi, N. AU - Sharkey, K. A. AU - Häyrinen-Immonen, R. PY - 2004 DA - 2004// TI - Recurrent aphthous ulcers today: a review of the growing knowledge JO - Int J Oral Maxillofac Surg VL - 3393 UR - https://doi.org/10.1006/ijom.2002.0446 DO - 10.1006/ijom.2002.0446 ID - Natah2004 ER - TY - STD TI - Chemocare. Skin reactions - managing side effects. http://chemocare.com/chemotherapy/side-effects/skin-reactions.aspx. Accessed 9 Nov 2016. UR - http://chemocare.com/chemotherapy/side-effects/skin-reactions.aspx ID - ref52 ER - TY - STD TI - British National Formulary. Metformin Hydrochloride. https://www.evidence.nhs.uk/formulary/bnf/current/6-endocrine-system/61-drugs-used-in-diabetes/612-antidiabetic-drugs/6122-biguanides/metformin-hydrochloride. Accessed 9 Nov 2016. UR - https://www.evidence.nhs.uk/formulary/bnf/current/6-endocrine-system/61-drugs-used-in-diabetes/612-antidiabetic-drugs/6122-biguanides/metformin-hydrochloride ID - ref53 ER - TY - JOUR AU - Sadowski, K. AU - Kotulska, K. AU - Jóźwiak, S. PY - 2016 DA - 2016// TI - Management of side effects of mTOR inhibitors in tuberous sclerosis patients JO - Pharmacol Rep VL - 68 UR - https://doi.org/10.1016/j.pharep.2016.01.005 DO - 10.1016/j.pharep.2016.01.005 ID - Sadowski2016 ER - TY - JOUR AU - Schwartz, M. AU - Roayaie, S. AU - Konstadoulakis, M. PY - 2007 DA - 2007// TI - Strategies for the management of hepatocellular carcinoma JO - Nat Clin Pract Oncol VL - 4 UR - https://doi.org/10.1038/ncponc0844 DO - 10.1038/ncponc0844 ID - Schwartz2007 ER - TY - JOUR AU - Robles, N. R. AU - Peces, R. AU - Gómez-Ferrer, Á. AU - Villacampa, F. AU - Álvarez-Ossorio, J. L. AU - Pérez-Segura, P. PY - 2016 DA - 2016// TI - Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial JO - Orphanet J Rare Dis VL - 11 UR - https://doi.org/10.1186/s13023-016-0517-9 DO - 10.1186/s13023-016-0517-9 ID - Robles2016 ER - TY - JOUR AU - Fogarasi, A. AU - Waele, L. AU - Bartalini, G. AU - Jozwiak, S. AU - Laforgia, N. AU - Verhelst, H. PY - 2016 DA - 2016// TI - EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex JO - BMC Neurol VL - 16 UR - https://doi.org/10.1186/s12883-016-0658-4 DO - 10.1186/s12883-016-0658-4 ID - Fogarasi2016 ER - TY - JOUR AU - Kingswood, J. C. AU - Bruzzi, P. AU - Curatolo, P. AU - Vries, P. J. AU - Fladrowski, C. AU - Hertzberg, C. PY - 2014 DA - 2014// TI - TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex JO - Orphanet J Rare Dis VL - 9 UR - https://doi.org/10.1186/s13023-014-0182-9 DO - 10.1186/s13023-014-0182-9 ID - Kingswood2014 ER -